Search Results

Filter
  • 1-10 of  21,096 results for ""Glucagon-Like Peptide-1 Receptor agonists""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.

  • Authors : Niazi S; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, North Zealand Hospital, Hillerød Hospital, Hillerød, Denmark

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glaucoma*/Glaucoma*/Glaucoma*/epidemiology ; Glaucoma*/Glaucoma*/Glaucoma*/drug therapy

  • Source: Ophthalmology [Ophthalmology] 2024 Sep; Vol. 131 (9), pp. 1056-1063. Date of Electronic Publication: 2024 Mar 13.Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical progress note: Glucagon-like peptide-1 receptor agonists and hospitalized patients.

  • Authors : Ravee A; Division of General Internal Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA.; Burroughs-Ray D

Subjects: Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Hospitalization* ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Journal of hospital medicine [J Hosp Med] 2024 Aug; Vol. 19 (8), pp. 716-719. Date of Electronic Publication: 2024 Apr 04.Publisher: Wiley Country of Publication: United States NLM ID: 101271025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

A comment on 'Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials'.

  • Authors : Goldenberg RM; LMC Diabetes & Endocrinology, Vaughan, Ontario, Canada.

Subjects: Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Thyroid Neoplasms*/Thyroid Neoplasms*/Thyroid Neoplasms*/chemically induced

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2997-2999. Date of Electronic Publication: 2024 Apr 04.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.

  • Authors : Milder DA; Department of Anaesthesia, Westmead Hospital, Westmead, NSW, Australia.; Milder TY

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Gastric Emptying*/Gastric Emptying*/Gastric Emptying*/drug effects

  • Source: Anaesthesia [Anaesthesia] 2024 Jul; Vol. 79 (7), pp. 735-747. Date of Electronic Publication: 2024 May 13.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study.

  • Authors : Su YC; Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Hsieh PC

Subjects: Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/surgery ; Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes & metabolism [Diabetes Metab] 2024 Jul; Vol. 50 (4), pp. 101545. Date of Electronic Publication: 2024 May 20.Publisher: Masson Country of Publication: France NLM ID: 9607599 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1780

Record details

×
Editorial & Opinion

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology.

  • Authors : Heymann WR; Division of Dermatology, Cooper Medical School of Rowan University, Camden, New Jersey. Electronic address: .

Subjects: Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jul; Vol. 91 (1), pp. 29-30. Date of Electronic Publication: 2024 Apr 30.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Editorial & Opinion

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus: Growing Evidence But Not Yet There.

  • Authors : Ginès P; Liver Unit, Hospital Clínic of Barcelona, Barcelona, Catalunya, Spain; School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalunya, Spain

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects

  • Source: Gastroenterology [Gastroenterology] 2024 Sep; Vol. 167 (4), pp. 653-655. Date of Electronic Publication: 2024 May 31.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment.

  • Authors : Jabbour S; Thomas Jefferson University, Philadelphia, Pennsylvania.; Paik JS

Subjects: Blood Glucose*/Blood Glucose*/Blood Glucose*/drug effects ; Blood Glucose*/Blood Glucose*/Blood Glucose*/analysis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Aug; Vol. 30 (8), pp. 701-709.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9607439 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study.

  • Authors : Ghazanfar H; Division of Gastroenterology, Department of Internal Medicine, BronxCare Health System, Icahn School of Medicine at Mount Sinai, Bronx, NY 10457, United States.; Javed N

Subjects: Gastroparesis*/Gastroparesis*/Gastroparesis*/epidemiology ; Gastroparesis*/Gastroparesis*/Gastroparesis*/etiology ; Gastroparesis*/Gastroparesis*/Gastroparesis*/prevention & control

  • Source: World journal of gastroenterology [World J Gastroenterol] 2024 Jul 14; Vol. 30 (26), pp. 3221-3228.Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Report

Efficacy of glucagon-like peptide-1 receptor agonists for psoriasis: An updated systematic review and meta-analysis.

  • Authors : Ku SC; Department of General Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Chang HC

Subjects: Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy; Humans

  • Source: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2024 Aug; Vol. 22 (8), pp. 1148-1152. Date of Publisher: Blackwell Country of Publication: Germany NLM ID: 101164708 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1610-0387

Record details

×
  • 1-10 of  21,096 results for ""Glucagon-Like Peptide-1 Receptor agonists""